High Expression of <scp>CHD1L</scp> , a Potent Oncogene Is Associated With Aggressive Head and Neck Cancer and Poor Survival Outcome
CHD1L is significantly upregulated in HNSCC and associated with poor survival outcomes. This suggests that CHD1L may serve as a potential therapeutic target and prognostic marker for HNSCC. Further research is necessary to explore the functional role of CHD1L in the development and progression of HNSCC.
Authors
- Paramasivam Arumugam
- Vijayashree Priyadharshini Jayaseelan
- Chandra Pandi
- Aishvarya Rukmani Panayappan
Institutions
- Saveetha University (IN)
Publication Details
- Journal
- Journal of Oral Pathology and Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1111/jop.70114
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.00